Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for vascular health in CKD/ESRD patients requiring AV fistula
NCT02414204Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Apr 2015
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of sildenafil in endothelial dysfunction and vascular stenosis, sponsored by University of Alabama at Birmingham. Primary endpoint: Flow-Mediated Dilation and Venous Plethysmography at 2 weeks. Started Apr 2015; status: completed.
02
Drugs
sildenafil
03
Conditions
endothelial dysfunctionvascular stenosis
Beyond the preview
Go deeper on NCT02414204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02414204.